Cure My Disease

Don't miss your cure!

 Log in / Sign up

A natural supplement combo could give hearts a boost

NCT ID NCT07792005

Disease control Sponsor: Hospital Pengajar Universiti Putra Malaysia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This trial tests whether a daily supplement combining sacha inchi oil and coenzyme Q10 can improve heart function and reduce cardiovascular risk in adults aged 40 to 75 who have risk factors like high blood pressure, high cholesterol, or diabetes. Participants take either the supplement or a placebo for 12 weeks. Researchers measure heart function, blood pressure, cholesterol, blood sugar, inflammation, and oxidative stress to see if the supplement helps. The study also checks whether the supplement is safe and well tolerated.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sacha Inchi-CoQ10 supplement (a combination of sacha inchi oil and coenzyme Q10, taken as softgels)
What this could lead to
If it works, this supplement could offer a simple, natural way to support heart health and lower cardiovascular risk in people who are already at higher risk.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The supplement may not improve heart function or risk factors, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 40 to 75 years. * Male or female. * Have one or more cardiovascular risk factors or stable cardiovascular disease, including: Hypertension; Dyslipidaemia; Controlled diabetes mellitus; or High cardiovascular risk, defined as Framingham Risk Score ≥10%. * Able to provide written informed consent. * Able and willing to comply with the study procedures and follow-up visits. Exclusion Criteria: * Unstable cardiovascular disease. * Severe renal impairment. * Severe hepatic impairment. * Active malignancy. * Pregnant or lactating women. * Known allergy to any study components. * Current use of omega-3, Sacha Inchi oil or Coenzyme Q10 supplements within the past three months. * Participation in another clinical trial within the past three months. * Impaired decision-making capacity, including cognitive impairment or severe mental disorder.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular disease (CVD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular disease (CVD) Elevated cardiovascular risk Endothelial dysfunction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.